The CBER Biologics Effectiveness and Safety (BEST) Initiative #3: Data Sources for Surveillance of Biologics (BEST 3) 3
ID: FDA-SOL-1224068 • Type: Solicitation
Overview
Response Deadline
July 23, 2020, 1:00 p.m. EDT
Past Due
Posted
June 24, 2020, 10:31 a.m. EDT (updated: July 13, 2020, 4:23 p.m. EDT)
Set Aside
None
NAICS
Place of Performance
Not Provided
Source
Current SBA Size Standard
$40 Million
Pricing
Likely Fixed Price
Est. Level of Competition
Average
On 6/24/20 Food and Drug Administration issued Solicitation FDA-SOL-1224068 for The CBER Biologics Effectiveness and Safety (BEST) Initiative #3: Data Sources for Surveillance of Biologics (BEST 3) due 7/23/20.
The opportunity was issued full & open with NAICS 518210 and PSC B537.
Primary Contact
Documents
Posted documents for Solicitation FDA-SOL-1224068
Question & Answer
Opportunity Lifecycle
Procurement notices related to Solicitation FDA-SOL-1224068
Award Notifications
Agency published notification of awards for Solicitation FDA-SOL-1224068
IDV Awards
Indefinite delivery vehicles awarded through Solicitation FDA-SOL-1224068
Incumbent or Similar Awards
Potential Bidders and Partners
Awardees that have won contracts similar to Solicitation FDA-SOL-1224068
Similar Active Opportunities
Open contract opportunities similar to Solicitation FDA-SOL-1224068
Additional Details
Source Agency Hierarchy
HEALTH AND HUMAN SERVICES, DEPARTMENT OF > FOOD AND DRUG ADMINISTRATION > FDA OFFICE OF ACQ GRANT SVCS
FPDS Organization Code
7524-00223
Source Organization Code
100188033
Last Updated
Aug. 7, 2020
Last Updated By
PI33_DR_IAE_51681
Archive Date
Aug. 7, 2020